Howe & Rusling’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.3M | Buy |
38,693
+7,319
| +23% | +$2.41M | 0.74% | 39 |
|
|
2025
Q4 | $11M | Buy |
31,374
+484
| +2% | +$164K | 0.73% | 38 |
|
|
2025
Q3 | $9.98M | Buy |
30,890
+18,469
| +149% | +$5.74M | 0.68% | 46 |
|
|
2025
Q2 | $4.83M | Buy |
+12,421
| New | +$5M | 0.36% | 77 |
|
|
2022
Q4 | – | Sell |
-28
| Closed | -$13K | – | 540 |
|
|
2022
Q3 | $13K | Buy |
28
+5
| +22% | +$2.39K | ﹤0.01% | 491 |
|
|
2022
Q2 | $11K | Sell |
23
-17
| -43% | -$8.41K | ﹤0.01% | 519 |
|
|
2022
Q1 | $20K | Hold |
40
| – | – | ﹤0.01% | 419 |
|
|
2021
Q4 | $19K | Hold |
40
| – | – | ﹤0.01% | 436 |
|
|
2021
Q3 | $15K | Hold |
40
| – | – | ﹤0.01% | 450 |
|
|
2021
Q2 | $15K | Hold |
40
| – | – | ﹤0.01% | 438 |
|
|
2021
Q1 | $14K | Sell |
40
-11
| -22% | -$3.54K | ﹤0.01% | 448 |
|
|
2020
Q4 | $16K | Hold |
51
| – | – | ﹤0.01% | 425 |
|
|
2020
Q3 | $14K | Hold |
51
| – | – | ﹤0.01% | 388 |
|
|
2020
Q2 | $13K | Buy |
51
+16
| +46% | +$4.27K | ﹤0.01% | 398 |
|
|
2020
Q1 | $8K | Buy |
+35
| New | +$9.54K | ﹤0.01% | 446 |
|
|
2019
Q2 | – | Sell |
-1
| Closed | – | – | 834 |
|
|
2019
Q1 | $0 | Buy |
+1
| New | +$289 | ﹤0.01% | 830 |
|
|
2017
Q3 | – | Sell |
-37
| Closed | -$7K | – | 901 |
|
|
2017
Q2 | $7K | Sell |
37
-402
| -92% | -$72.2K | ﹤0.01% | 549 |
|
|
2017
Q1 | $73K | Sell |
439
-8
| -2% | -$1.27K | 0.01% | 223 |
|
|
2016
Q4 | $64K | Sell |
447
-55
| -11% | -$7.36K | 0.01% | 247 |
|
|
2016
Q3 | $63K | Sell |
502
-312
| -38% | -$40.3K | 0.01% | 236 |
|
|
2016
Q2 | $107K | Sell |
814
-298
| -27% | -$40.8K | 0.02% | 181 |
|
|
2016
Q1 | $155K | Sell |
1,112
-6
| -0.5% | -$802 | 0.03% | 159 |
|
|
2015
Q4 | $156K | Sell |
1,118
-986
| -47% | -$136K | 0.04% | 163 |
|
|
2015
Q3 | $295K | Sell |
2,104
-85
| -4% | -$12.8K | 0.07% | 124 |
|
|
2015
Q2 | $359K | Sell |
2,189
-758
| -26% | -$121K | 0.08% | 126 |
|
|
2015
Q1 | $455K | Sell |
2,947
-22
| -0.7% | -$3.13K | 0.1% | 115 |
|
|
2014
Q4 | $373K | Buy |
2,969
+88
| +3% | +$10.9K | 0.09% | 123 |
|
|
2014
Q3 | $345K | Sell |
2,881
-42
| -1% | -$4.82K | 0.08% | 126 |
|
|
2014
Q2 | $315K | Sell |
2,923
-132
| -4% | -$13.6K | 0.07% | 131 |
|
|
2014
Q1 | $304K | Sell |
3,055
-30
| -1% | -$2.71K | 0.07% | 124 |
|
|
2013
Q4 | $285K | Sell |
3,085
-255
| -8% | -$22.7K | 0.07% | 125 |
|
|
2013
Q3 | $280K | Sell |
3,340
-297
| -8% | -$25.5K | 0.1% | 119 |
|
|
2013
Q2 | $298K | Buy |
+3,637
| New | +$272K | 0.08% | 136 |
|
Other funds holding ELV
VCM
VPM
Howe & Rusling's ELV Position: Q1 2026 in Review
Howe & Rusling increased its Elevance Health (ELV) stake by 23% in Q1 2026, buying an estimated $2.41M and bringing the position to 38,693 shares worth $11.3M. The position accounts for 0.74% of the portfolio, ranked #39.
Howe & Rusling first reported a position in ELV in Q2 2013 and has held it in 33 quarters since. 1,465 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Howe & Rusling held 38,693 shares of Elevance Health worth $11.3M as of Q1 2026.
- Howe & Rusling bought 7,319 Elevance Health shares in Q1 2026, an estimated $2.41M.
- Elevance Health made up 0.74% of Howe & Rusling's portfolio in Q1 2026, its #39 holding.
- Howe & Rusling first reported a position in Elevance Health in Q2 2013 and has held it in 33 quarters since.
- 1,465 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Howe & Rusling's 13F filing for Q1 2026, filed 28 Apr 2026.